Swiss firm Lonza said Wednesday it will open a new production line for the drug substance in Moderna’s COVID-19 vaccine, making it possible to churn out hundreds of millions more jabs per year. The new line will be set up at Lonza’s site in Geleen, Netherlands, and is expected to begin production by the end […]